Abstract
The κ-opioid receptor (KOR) system has been implicated in the regulation of many behaviors including pain. While there are numerous studies suggesting KOR regulation of pain being mediated spinally, there have been reports of pain-like behaviors regulated by central KOR signaling. In particular, oxytocin-induced analgesia appears to be mediated by KOR receptors within the ventrolateral periaqueductal gray (vlPAG). We recently found that activation of dopamine (DA) neurons within the vlPAG is antinociceptive. In this study, we sought to determine the impact of KOR signaling on -GABAergic inputs onto vlPAG DA neurons, and the mechanism through which KOR impacts these inputs. We found that activation of KOR reduced GABAergic transmission onto vlPAG DA neurons. In addition, our data suggest this effect is mediated presynaptically via the G protein βγ-subunit. They raise the possibility that KOR activation disinhibits -vlPAG DA neurons, which could lead to altered regulation of pain-related behaviors.
References
1.
Miller
JM
, Zanderigo
F
, Purushothaman
PD
, DeLorenzo
C
, Rubin-Falcone
H
, Ogden
RT
, et al. Kappa opioid receptor binding in major depression: A pilot study
. Synapse
. 2018
Sep
;72
(9
):e22042
.
[PubMed]
0887-44762.
Tejeda
HA
, Shippenberg
TS
, Henriksson
R
. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
. Cell Mol Life Sci
. 2012
Mar
;69
(6
):857
–96
.
[PubMed]
1420-682X3.
Koob
GF
. The dark side of emotion: the addiction perspective
. Eur J Pharmacol
. 2015
Apr
;753
:73
–87
.
[PubMed]
0014-29994.
Millan
MJ
. Kappa-opioid receptors and analgesia
. Trends Pharmacol Sci
. 1990
Feb
;11
(2
):70
–6
.
[PubMed]
0165-61475.
Peng
J
, Sarkar
S
, Chang
SL
. Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR
. Drug Alcohol Depend
. 2012
Aug
;124
(3
):223
–8
.
[PubMed]
0376-87166.
Chavkin
C
, James
IF
, Goldstein
A
. Dynorphin is a specific endogenous ligand of the kappa opioid receptor
. Science
. 1982
Jan
;215
(4531
):413
–5
.
[PubMed]
0036-80757.
Minneman
KP
, Iversen
IL
. Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum
. Nature
. 1976
Jul
;262
(5566
):313
–4
.
[PubMed]
0028-08368.
Taussig
R
, Iñiguez-Lluhi
JA
, Gilman
AG
. Inhibition of adenylyl cyclase by Gi alpha
. Science
. 1993
Jul
;261
(5118
):218
–21
.
[PubMed]
0036-80759.
Schattauer
SS
, Miyatake
M
, Shankar
H
, Zietz
C
, Levin
JR
, Liu-Chen
LY
, et al. Ligand directed signaling differences between rodent and human κ-opioid receptors
. J Biol Chem
. 2012
Dec
;287
(50
):41595
–607
.
[PubMed]
0021-925810.
Bruchas
MR
, Macey
TA
, Lowe
JD
, Chavkin
C
. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes
. J Biol Chem
. 2006
Jun
;281
(26
):18081
–9
.
[PubMed]
0021-925811.
Dhawan
BN
, Cesselin
F
, Raghubir
R
, Reisine
T
, Bradley
PB
, Portoghese
PS
, et al. International Union of Pharmacology. XII. Classification of opioid receptors
. Pharmacol Rev
. 1996
Dec
;48
(4
):567
–92
.
[PubMed]
0031-699712.
Grudt
TJ
, Williams
JT
. Opioid receptors and the regulation of ion conductances
. Rev Neurosci
. 1995
Jul-Sep
;6
(3
):279
–86
.
[PubMed]
0334-176313.
Li
C
, Pleil
KE
, Stamatakis
AM
, Busan
S
, Vong
L
, Lowell
BB
, et al. Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling
. Biol Psychiatry
. 2012
Apr
;71
(8
):725
–32
.
[PubMed]
0006-322314.
Bruchas
MR
, Land
BB
, Aita
M
, Xu
M
, Barot
SK
, Li
S
, et al. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria
. J Neurosci
. 2007
Oct
;27
(43
):11614
–23
.
[PubMed]
0270-647415.
Daniel
SE
, Rainnie
DG
. Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis
. Neuropsychopharmacology
. 2016
Jan
;41
(1
):103
–25
.
[PubMed]
0893-133X16.
Ahrens
S
, Wu
MV
, Furlan
A
, Hwang
GR
, Paik
R
, Li
H
, et al. A Central Extended Amygdala Circuit That Modulates Anxiety
. J Neurosci
. 2018
Jun
;38
(24
):5567
–83
.
[PubMed]
0270-647417.
Maruyama
C
, Deyama
S
, Nagano
Y
, Ide
S
, Kaneda
K
, Yoshioka
M
, et al. Suppressive effects of morphine injected into the ventral bed nucleus of the stria terminalis on the affective, but not sensory, component of pain in rats
. Eur J Neurosci
. 2018
Jan
;47
(1
):40
–7
.
[PubMed]
0953-816X18.
Tran
L
, Schulkin
J
, Greenwood-Van Meerveld
B
. Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain
. Neuropsychopharmacology
. 2014
Oct
;39
(11
):2633
–45
.
[PubMed]
0893-133X19.
Cho
JR
, Treweek
JB
, Robinson
JE
, Xiao
C
, Bremner
LR
, Greenbaum
A
, et al. Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient Stimuli
. Neuron
. 2017
Jun
;94
(6
):1205
–1219.e8
.
[PubMed]
0896-627320.
Matthews
GA
, Nieh
EH
, Vander Weele
CM
, Halbert
SA
, Pradhan
RV
, Yosafat
AS
, et al. Dorsal Raphe Dopamine Neurons Represent the Experience of Social Isolation
. Cell
. 2016
Feb
;164
(4
):617
–31
.
[PubMed]
0092-867421.
Ge
Y
, Lundeberg
T
, Yu
LC
. Blockade effect of mu and kappa opioid antagonists on the anti-nociception induced by intra-periaqueductal grey injection of oxytocin in rats
. Brain Res
. 2002
Feb
;927
(2
):204
–7
.
[PubMed]
0006-899322.
Margolis
EB
, Lock
H
, Chefer
VI
, Shippenberg
TS
, Hjelmstad
GO
, Fields
HL
. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex
. Proc Natl Acad Sci USA
. 2006
Feb
;103
(8
):2938
–42
.
[PubMed]
0027-842423.
Polter
AM
, Barcomb
K
, Chen
RW
, Dingess
PM
, Graziane
NM
, Brown
TE
, et al. Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress
. eLife
. 2017
Apr
;6
:6
.
[PubMed]
2050-084X24.
Gutstein
Hb
, et al., Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla. (0959-4965 (Print)).25.
Ukhanov
K
, Brunert
D
, Corey
EA
, Ache
BW
. Phosphoinositide 3-kinase-dependent antagonism in mammalian olfactory receptor neurons
. J Neurosci
. 2011
Jan
;31
(1
):273
–80
.
[PubMed]
0270-647426.
Ford
CP
, Mark
GP
, Williams
JT
. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location
. J Neurosci
. 2006
Mar
;26
(10
):2788
–97
.
[PubMed]
0270-647427.
Ford
CP
, Beckstead
MJ
, Williams
JT
. Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents
. J Neurophysiol
. 2007
Jan
;97
(1
):883
–91
.
[PubMed]
0022-307728.
Iremonger
KJ
, Bains
JS
. Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus
. J Neurosci
. 2009
Jun
;29
(22
):7349
–58
.
[PubMed]
0270-647429.
Blackmer
T
, Larsen
EC
, Takahashi
M
, Martin
TF
, Alford
S
, Hamm
HE
. G protein betagamma subunit-mediated presynaptic inhibition: regulation of exocytotic fusion downstream of Ca2+ entry
. Science
. 2001
Apr
;292
(5515
):293
–7
.
[PubMed]
0036-807530.
Delaney
AJ
, Crane
JW
, Sah
P
. Noradrenaline modulates transmission at a central synapse by a presynaptic mechanism
. Neuron
. 2007
Dec
;56
(5
):880
–92
.
[PubMed]
0896-6273© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
